HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.

AuthorsK Meijer, E Sieders, M J Slooff, J T de Wolf, J van der Meer
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 80 Issue 1 Pg. 204-5 (Jul 1998) ISSN: 0340-6245 [Print] Germany
PMID9684815 (Publication Type: Case Reports, Letter)
Chemical References
  • Recombinant Proteins
  • Factor VII
Topics
  • Aged
  • Blood Platelet Disorders (complications)
  • Drug Administration Schedule
  • Factor VII (therapeutic use)
  • Hemorrhage (drug therapy, etiology)
  • Humans
  • Male
  • Recombinant Proteins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: